Literature DB >> 17709166

A pilot study of key nursing aspects with different cooling methods and devices in the ICU.

Astrid Våga1, Michael Busch, Tom Erik Karlsen, Odd Bjarte Nilsen, Eldar Søreide.   

Abstract

INTRODUCTION: Therapeutic hypothermia (TH) has become an integrated part of neurointensive care. Still, little data exists on the actual experience with cooling patients in the ICU from the intensive care nurse (ICN) perspective. The purpose of this survey was to evaluate important nursing aspects with different cooling methods and devices in ICU use.
MATERIALS AND METHODS: The ICNs used a four-point rating scale (1=worst, 4=best possible) to evaluate (a) ease of application, (b) visual patient monitoring, (c) work load, (d) hygiene and (e) noise level with four cooling methods used in our ICU. Our simple, initial method of towels soaked in iced water spread over the torso was compared to three commercial cooling methods used; (1) Coolgard 3000 (Alsius, Irvine, USA), (2) Thermowrap (MTRE, Yavne, Israel) and (3) Artic Sun (Medivance, Louisville, USA). RESULT: There were significant differences in how the ICNs rated the nursing aspects of the different cooling methods. Ice-water soaked towels over the torso scored high with respect to ease of application and noise level. For work-load, all the three commercial devices scored significantly better than ice-water soaked towels (P<0.05). Only the Coolgard 3000 system scored significantly better than ice-water soaked towels for visual patient monitoring (P<0.001). For hygienic aspects, Artic Sun and Coolgard scored significantly higher than the others (P<0.05). Overall, the ICNs involved felt they had a general good understanding of TH but were only partly prepared in terms of training and knowledge of protocols and complications when TH was introduced in our ICU. The majority felt the new cooling protocol was acceptable.
CONCLUSION: We identified significant differences in the rating of key nursing aspects of the different cooling methods. More studies on implementation of new cooling methods and devices seem warranted.

Entities:  

Mesh:

Year:  2007        PMID: 17709166     DOI: 10.1016/j.resuscitation.2007.07.008

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  6 in total

Review 1.  Use of hypothermia in the intensive care unit.

Authors:  Jesse J Corry
Journal:  World J Crit Care Med       Date:  2012-08-04

Review 2.  The Implementation of Targeted Temperature Management: An Evidence-Based Guideline from the Neurocritical Care Society.

Authors:  Lori Kennedy Madden; Michelle Hill; Teresa L May; Theresa Human; Mary McKenna Guanci; Judith Jacobi; Melissa V Moreda; Neeraj Badjatia
Journal:  Neurocrit Care       Date:  2017-12       Impact factor: 3.210

3.  Evaluation of 2 Heat-Mitigation Methods in Army Trainees.

Authors:  JoEllen M Sefton; J S McAdam; David D Pascoe; K R Lohse; Robert L Banda; Corbin B Henault; Andrew R Cherrington; N E Adams
Journal:  J Athl Train       Date:  2016-10-06       Impact factor: 2.860

Review 4.  Out-of-hospital therapeutic hypothermia in cardiac arrest victims.

Authors:  Wilhelm Behringer; Jasmin Arrich; Michael Holzer; Fritz Sterz
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-10-12       Impact factor: 2.953

5.  Factors predicting the use of therapeutic hypothermia and survival in unconscious out-of-hospital cardiac arrest patients admitted to the ICU.

Authors:  T W Lindner; J Langørgen; K Sunde; A I Larsen; J T Kvaløy; J K Heltne; T Draegni; E Søreide
Journal:  Crit Care       Date:  2013-07-23       Impact factor: 9.097

6.  Breakthrough in cardiac arrest: reports from the 4th Paris International Conference.

Authors:  Peter J Kudenchuk; Claudio Sandroni; Hendrik R Drinhaus; Bernd W Böttiger; Alain Cariou; Kjetil Sunde; Martin Dworschak; Fabio Silvio Taccone; Nicolas Deye; Hans Friberg; Steven Laureys; Didier Ledoux; Mauro Oddo; Stéphane Legriel; Philippe Hantson; Jean-Luc Diehl; Pierre-Francois Laterre
Journal:  Ann Intensive Care       Date:  2015-09-17       Impact factor: 6.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.